Abstract
Patients with long-standing ulcerative colitis (UC) have an increased risk of colorectal neoplasia (from dysplasia to advanced cancer) and are therefore candidates for several kinds of surgical treatments, ranging from an endoscopic resection to abdominoperineal resection and total proctocolectomy, depending on disease status. In addition to the extent of resection, patient age and sex, anal function, UC status, and type or location of the neoplasia must be taken into account in surgical decision-making. Although total proctocolectomy with ileal pouch-anal anastomosis is the gold standard for UC-associated colorectal cancer, the pros and cons of rectal mucosectomy are still debated. In addition, the postoperative administration of immunomodulators or biologics for UC is controversial. Data on the prognosis of surgically treated patients are still limited, and conclusions cannot yet be drawn. However, these patients should be closely followed for a relapse of inflammation and the recurrence of neoplasia in the residual lesion, especially in the anal transition zone. Recent, more aggressive approaches include chemoradiotherapy followed by ileal pouch-anal anastomosis or partial intersphincteric resection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kaplan GG et al (2012) Decreasing colectomy rates for ulcerative colitis: a population-based time trend study. Am J Gastroenterol 107(12):1879–1887
Mpofu C, Watson AJ, Rhodes JM (2004) Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2:CD000279
Eaden JA, Abrams KR, Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48(4):526–535
Ullman TA, Itzkowitz SH (2011) Intestinal inflammation and cancer. Gastroenterology 140(6):1807–1816
Riddell RH et al (1983) Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14(11):931–968
Melville DM et al (1988) Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlations. Gastroenterology 95(3):668–675
Lofberg R et al (1990) Colonoscopic surveillance in long-standing total ulcerative colitis–a 15-year follow-up study. Gastroenterology 99(4):1021–1031
Burmer GC et al (1992) Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology 103(5):1602–1610
Leedham SJ et al (2009) Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia. Gastroenterology 136(2):542–550, e6
Galandiuk S et al (2012) Field cancerization in the intestinal epithelium of patients with Crohn’s ileocolitis. Gastroenterology 142(4):855–864, e8
Lyda MH et al (2000) Microsatellite instability and K-ras mutations in patients with ulcerative colitis. Hum Pathol 31(6):665–671
Itzkowitz SH, Yio X (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287(1):G7–G17
Gorfine SR et al (2000) Dysplasia complicating chronic ulcerative colitis: is immediate colectomy warranted? Dis Colon Rectum 43(11):1575–1581
Gumaste V, Sachar DB, Greenstein AJ (1992) Benign and malignant colorectal strictures in ulcerative colitis. Gut 33(7):938–941
Murphy J et al (2014) Dysplasia in ulcerative colitis as a predictor of unsuspected synchronous colorectal cancer. Dis Colon Rectum 57(8):993–998
Lennard-Jones JE et al (1990) Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 31(7):800–806
Leidenius M et al (1991) Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme. Gut 32(12):1521–1525
Nugent FW, Haggitt RC, Gilpin PA (1991) Cancer surveillance in ulcerative colitis. Gastroenterology 100(5 Pt 1):1241–1248
Lashner BA, Kane SV, Hanauer SB (1990) Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol 85(9):1083–1087
Lynch DA et al (1993) Failure of colonoscopic surveillance in ulcerative colitis. Gut 34(8):1075–1080
Lashner BA, Silverstein MD, Hanauer SB (1989) Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci 34(10):1536–1541
Bernstein CN, Shanahan F, Weinstein WM (1994) Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 343(8889):71–74
Saito Y et al (1995) Total colectomy and ileorectal anastomosis in ulcerative colitis. J Gastroenterol 30(Suppl 8):131–134
Nugent FW et al (1979) Malignant potential of chronic ulcerative colitis. Preliminary report. Gastroenterology 76(1):1–5
Woolrich AJ, DaSilva MD, Korelitz BI (1992) Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology 103(2):431–438
Ullman T et al (2003) Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 125(5):1311–1319
Connell WR et al (1994) Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 107(4):934–944
Zisman TL et al (2012) Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines. Inflamm Bowel Dis 18(12):2240–2246
Lim CH et al (2003) Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut 52(8):1127–1132
Itzkowitz SH, Harpaz N (2004) Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 126(6):1634–1648
Kiran RP et al (2014) Risk and location of cancer in patients with preoperative colitis-associated dysplasia undergoing proctocolectomy. Ann Surg 259(2):302–309
Ullman TA et al (2002) The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol 97(4):922–927
Kornbluth A, Sachar DB (2010) Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 105(3):501–523; quiz 524
Farraye FA et al (2010) AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 138(2):738–745
Farraye FA et al (2010) AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 138(2):746–774, 774 e1-4; quiz e12-3
Itzkowitz SH, Present DH (2005) Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 11(3):314–321
Eaden JA, Mayberry JF (2002) Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 51(Suppl 5):V10–V12
Das P et al (2007) Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis. Color Dis 9(1):15–27
Venkatesh PG et al (2013) Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis. J Crohns Colitis 7(12):968–973
Blackstone MO et al (1981) Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 80(2):366–374
Blonski W et al (2008) High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitis. Scand J Gastroenterol 43(7):817–820
Odze RD et al (2004) Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2(7):534–541
Rubin PH et al (1999) Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 117(6):1295–1300
Engelsgjerd M, Farraye FA, Odze RD (1999) Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 117(6):1288–1294; discussion 1488–91
Odze RD (1999) Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological, and molecular review. Am J Gastroenterol 94(7):1746–1750
Brooke BN (1961) Malignant change in ulcerative colitis. Dis Colon Rectum 4:393–398
Truelove SC, Witts LJ (1955) Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 2(4947):1041–1048
Lashner BA et al (1990) Dysplasia and cancer complicating strictures in ulcerative colitis. Dig Dis Sci 35(3):349–352
Sugita A et al (1993) Survival with colorectal cancer in ulcerative colitis. A study of 102 cases. Ann Surg 218(2):189–195
Varma JS et al (1987) Mucosal proctectomy and colo-anal anastomosis for distal ulcerative proctocolitis. Br J Surg 74(5):381–383
Schwarz RJ, Pezim ME (1991) Failure of right-sided coloanal anastomosis for treatment of left-sided ulcerative colitis. Report of a case. Dis Colon Rectum 34(7):618–621
Sebastian S et al (2014) Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I). J Crohns Colitis 8(1):5–18
Glickman JN, Odze RD (2008) Does rectal sparing ever occur in ulcerative colitis? Inflamm Bowel Dis 14(Suppl 2):S166–S167
Bousvaros A et al (2007) Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn’s and Colitis Foundation of America. J Pediatr Gastroenterol Nutr 44(5):653–674
Rajwal SR et al (2004) Endoscopic rectal sparing in children with untreated ulcerative colitis. J Pediatr Gastroenterol Nutr 38(1):66–69
Robert ME et al (2004) Patterns of inflammation in mucosal biopsies of ulcerative colitis: perceived differences in pediatric populations are limited to children younger than 10 years. Am J Surg Pathol 28(2):183–189
Yantiss RK, Odze RD (2007) Pitfalls in the interpretation of nonneoplastic mucosal biopsies in inflammatory bowel disease. Am J Gastroenterol 102(4):890–904
Joo M, Odze RD (2010) Rectal sparing and skip lesions in ulcerative colitis: a comparative study of endoscopic and histologic findings in patients who underwent proctocolectomy. Am J Surg Pathol 34(5):689–696
Andersson P et al (2014) Ileorectal anastomosis in comparison with ileal pouch anal anastomosis in reconstructive surgery for ulcerative colitis–a single institution experience. J Crohns Colitis 8(7):582–589
Johnson WR et al (1986) The outcome of patients with ulcerative colitis managed by subtotal colectomy. Surg Gynecol Obstet 162(5):421–425
Romano G et al (1987) Role of ileorectal anastomosis in the treatment of ulcerative colitis and familial polyposis. Ital J Surg Sci 17(2):135–140
Oakley JR et al (1985) The fate of the rectal stump after subtotal colectomy for ulcerative colitis. Dis Colon Rectum 28(6):394–396
Baker WN et al (1978) Cancer of the rectum following colectomy and ileorectal anastomosis for ulcerative colitis. Br J Surg 65(12):862–868
Selvaggi F et al (2014) Systematic review of cuff and pouch cancer in patients with ileal pelvic pouch for ulcerative colitis. Inflamm Bowel Dis 20(7):1296–1308
Lutgens MW et al (2012) Risk factors for rectal stump cancer in inflammatory bowel disease. Dis Colon Rectum 55(2):191–196
Utsunomiya J et al (1980) Total colectomy, mucosal proctectomy, and ileoanal anastomosis. Dis Colon Rectum 23(7):459–466
Kim WH et al (1999) Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn’s disease and intestinal Behcet’s disease. Int J Color Dis 14(1):52–57
Cheung WY et al (2000) The UK IBDQ-a British version of the inflammatory bowel disease questionnaire. development and validation. J Clin Epidemiol 53(3):297–306
Watanabe K et al (2006) Assessment of the Japanese Inflammatory Bowel Disease Questionnaire in patients after ileal pouch anal anastomosis for ulcerative colitis. J Gastroenterol 41(7):662–667
Burnstein MJ et al (1987) Technique of mesenteric lengthening in ileal reservoir-anal anastomosis. Dis Colon Rectum 30(11):863–866
Araki T et al (2007) An alternative conversion technique for salvaging a failed ileal J-pouch-anal anastomosis to a modified H-pouch. Dig Surg 24(5):324–327
Kusunoki M et al (1999) Current trends in restorative proctocolectomy: introduction of an ultrasonically activated scalpel. Dis Colon Rectum 42(10):1349–1352
Tekkis PP et al (2005) Evaluation of the learning curve in ileal pouch-anal anastomosis surgery. Ann Surg 241(2):262–268
Heuschen UA et al (2002) Outcome after septic complications in J pouch procedures. Br J Surg 89(2):194–200
Ziv Y et al (1994) Incidence, risk factors, and treatment of dysplasia in the anal transitional zone after ileal pouch-anal anastomosis. Dis Colon Rectum 37(12):1281–1285
Chia CS et al (2008) Adenocarcinoma of the anal transitional zone after double stapled ileal pouch-anal anastomosis for ulcerative colitis. Color Dis 10(6):621–623
Al-Sukhni W et al (2010) Oncologic outcome in patients with ulcerative colitis associated with dysplasia or cancer who underwent stapled or handsewn ileal pouch-anal anastomosis. Dis Colon Rectum 53(11):1495–1500
O’Riordain MG et al (2000) Incidence and natural history of dysplasia of the anal transitional zone after ileal pouch-anal anastomosis: results of a five-year to ten-year follow-up. Dis Colon Rectum 43(12):1660–1665
Alessandroni L et al (2012) Adenocarcinoma below stapled ileoanal anastomosis after restorative proctocolectomy for ulcerative colitis. Updat Surg 64(2):149–152
Pedersen ME et al (2008) Adenocarcinoma arising from the rectal stump eleven years after excision of an ileal J-pouch in a patient with ulcerative colitis: report of a case. Dis Colon Rectum 51(7):1146–1148
Sagayama K et al (2007) Incidence of and risk factors for dysplasia in mucosectomy area in ulcerative colitis patients undergoing restorative proctocolectomy. Int J Color Dis 22(4):439–443
Tsunoda A, Talbot IC, Nicholls RJ (1990) Incidence of dysplasia in the anorectal mucosa in patients having restorative proctocolectomy. Br J Surg 77(5):506–508
Remzi FH et al (2003) Dysplasia of the anal transitional zone after ileal pouch-anal anastomosis: results of prospective evaluation after a minimum of ten years. Dis Colon Rectum 46(1):6–13
Johnston D et al (1987) Preservation of the entire anal canal in conservative proctocolectomy for ulcerative colitis: a pilot study comparing end-to-end ileo-anal anastomosis without mucosal resection with mucosal proctectomy and endo-anal anastomosis. Br J Surg 74(10):940–944
Galli-Gallardo SM, Pang PK, Oguro C (1979) Renal responses of the chilean toad, Calyptocephalella caudiverbera, and the mud puppy, Necturus maculosus, to mesotocin. Gen Comp Endocrinol 37(1):134–136
Remzi FH, Preen M (2003) Rectal cancer and ulcerative colitis: does it change the therapeutic approach? Color Dis 5(5):483–485
Bauer JJ et al (1997) Restorative proctocolectomy in patients older than fifty years. Dis Colon Rectum 40(5):562–565
Branco BC et al (2009) Adenocarcinoma complicating restorative proctocolectomy for ulcerative colitis with mucosectomy performed by Cavitron Ultrasonic Surgical Aspirator. Color Dis 11(4):428–429
Heimann TM et al (1984) Mucosal proctectomy using an ultrasonic scalpel. Am J Surg 147(6):803–806
Monkemuller K et al (2009) Advanced colon polypectomy. Clin Gastroenterol Hepatol 7(6):641–652
Vieth M, Behrens H, Stolte M (2006) Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment. Gut 55(8):1151–1155
Rutter MD et al (2006) Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 130(4):1030–1038
Neumann H et al (2011) Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. World J Gastroenterol 17(27):3184–3191
Kisiel JB et al (2012) Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy. Inflamm Bowel Dis 18(2):226–235
American Society for Gastrointestinal Endoscopy (ASGE) (1998) The role of colonoscopy in the management of patients with inflammatory bowel disease. Gastrointest Endosc 48(6):689–690
Mowat C et al (2011) Guidelines for the management of inflammatory bowel disease in adults. Gut 60(5):571–607
Magro F et al (2013) European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 7(10):827–851
Hurlstone DP et al (2007) Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm? Gut 56(6):838–846
Sandborn WJ, Loftus EV (2004) Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease. Gut 53(6):780–782
Dixon WG et al (2010) Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register. Arthritis Care Res (Hoboken) 62(6):755–763
Karran P, Attard N (2008) Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer. Nat Rev Cancer 8(1):24–36
Vivarelli M et al (2008) Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. Ann Surg 248(5):857–862
Askling J et al (2011) Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data. Pharmacoepidemiol Drug Saf 20(2):119–130
Sigler L, Jedd FL (1969) Adenocarcinoma of the ileostomy occurring after colectomy for ulcerative colitis: report of a case. Dis Colon Rectum 12(1):45–48
Cuesta MA, Donner R (1976) Adenocarcinoma arising at an ileostomy site: report of a case. Cancer 37(2):949–952
Stryker SJ (1983) Primary stomal adenocarcinoma. An unusual complication of ileostomy. Dis Colon Rectum 26(1):47–49
Roberts PL et al (1989) Adenocarcinoma arising in an ileostomy. Report of two cases and review of the literature. Arch Surg 124(4):497–499
Cox CL et al (1997) Development of invasive adenocarcinoma in a long-standing Kock continent ileostomy: report of a case. Dis Colon Rectum 40(4):500–503
Nilubol N et al (2007) Mucosal dysplasia in ileal pelvic pouches after restorative proctocolectomy. Dis Colon Rectum 50(6):825–831
Derikx LA et al (2014) Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease. Gastroenterology 146(1):119–128, e1
Knupper N et al (2006) Adenocarcinoma of the ileoanal pouch for ulcerative colitis--a complication of severe chronic atrophic pouchitis? Int J Color Dis 21(5):478–482
Branco BC et al (2009) Adenocarcinoma following ileal pouch-anal anastomosis for ulcerative colitis: review of 26 cases. Inflamm Bowel Dis 15(2):295–299
Giebel GD, Sabiers H (1996) Ileal pouch-anal anastomosis for ulcerative colitis and polyposis coli: is the risk of carcinoma formation conclusively averted? Eur J Surg Oncol 22(4):372–376
Heuschen UA et al (2001) Adenocarcinoma in the ileal pouch: late risk of cancer after restorative proctocolectomy. Int J Color Dis 16(2):126–130
Herfarth C, Heuschen G, Heuschen UA (1998) Malignant transformation in ulcerative colitis and surgical implications. Chirurg 69(10):1020–1027
Lofberg R et al (1991) Dysplasia and DNA aneuploidy in a pelvic pouch. Report of a case. Dis Colon Rectum 34(3):280–283; discussion 283–4
Veress B et al (1995) Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a subgroup of patients. Gastroenterology 109(4):1090–1097
Carey PD et al (1993) Primary adenocarcinoma in an ileostomy: a late complication of surgery for ulcerative colitis. Surgery 113(6):712–715
Imam MH et al (2014) Neoplasia in the ileoanal pouch following colectomy in patients with ulcerative colitis and primary sclerosing cholangitis. J Crohns Colitis 8(10):1294–1299
Kim BJ et al (2009) Trends of ulcerative colitis-associated colorectal cancer in Korea: A KASID study. J Gastroenterol Hepatol 24(4):667–671
Hughes RG et al (1978) The prognosis of carcinoma of the colon and rectum complicating ulcerative colitis. Surg Gynecol Obstet 146(1):46–48
Lavery IC et al (1982) Survival with carcinoma arising in mucosal ulcerative colitis. Ann Surg 195(4):508–512
Ritchie JK, Hawley PR, Lennard-Jones JE (1981) Prognosis of carcinoma in ulcerative colitis. Gut 22(9):752–755
Gorfine SR et al (2004) Restorative proctocolectomy for ulcerative colitis complicated by colorectal cancer. Dis Colon Rectum 47(8):1377–1385
Delaunoit T et al (2006) Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 4(3):335–342
Heimann TM et al (1992) Colorectal carcinoma associated with ulcerative colitis: a study of prognostic indicators. Am J Surg 164(1):13–17
Kavanagh DO et al (2014) Management of colorectal cancer in patients with inflammatory bowel disease. Tech Coloproctol 18(1):23–28
Watanabe T et al (2011) Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis 17(3):802–808
Jensen AB et al (2006) Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study. Am J Gastroenterol 101(6):1283–1287
Larsen M et al (2007) Survival after colorectal cancer in patients with Crohn’s disease: A nationwide population-based Danish follow-up study. Am J Gastroenterol 102(1):163–167
Shu X et al (2011) Survival in cancer patients hospitalized for inflammatory bowel disease in Sweden. Inflamm Bowel Dis 17(3):816–822
Inoue Y et al (2014) Chemoradiotherapy followed by restorative proctocolectomy with partial intersphincteric resection for advanced rectal cancer associated with ulcerative colitis: report of a case. Surg Today 44(2):387–390
Radice E et al (1998) Ileal pouch-anal anastomosis in patients with colorectal cancer: long-term functional and oncologic outcomes. Dis Colon Rectum 41(1):11–17
Wu XR et al (2013) Preoperative pelvic radiation increases the risk for ileal pouch failure in patients with colitis-associated colorectal cancer. J Crohns Colitis 7(10):e419–e426
Emami B et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21(1):109–122
Adenis A et al (2007) Bevacizumab and postponed suture leakages after surgery for ulcerative colitis and rectal cancer. Gut 56(5):734
Da Silva GM et al (2003) Histologic analysis of the irradiated anal sphincter. Dis Colon Rectum 46(11):1492–1497
Lorenzi B et al (2012) Short-term effects of neoadjuvant chemoradiotherapy on internal anal sphincter function: a human in vitro study. Dis Colon Rectum 55(4):465–472
Ito M et al (2009) Analysis of clinical factors associated with anal function after intersphincteric resection for very low rectal cancer. Dis Colon Rectum 52(1):64–70
Rodriguez-Enriquez S et al (2014) Canonical and new generation anticancer drugs also target energy metabolism. Arch Toxicol 88(7):1327–1350
Inoue Y, Kusunoki M (2010) Resection of rectal cancer: a historical review. Surg Today 40(6):501–506
Inoue Y et al (2011) Push-back technique facilitates ultra-low anterior resection without nerve injury in total mesorectal excision for rectal cancer. Dig Surg 28(4):239–244
Kusunoki M et al (1992) Modified anoabdominal rectal resection and colonic J-pouch anal anastomosis for lower rectal carcinoma: preliminary report. Surgery 112(5):876–883
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Japan
About this chapter
Cite this chapter
Araki, T. et al. (2016). Surgical Treatment for Ulcerative Colitis-Associated Cancer or Dysplasia. In: Kusunoki, M. (eds) Colitis-Associated Cancer. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55522-3_6
Download citation
DOI: https://doi.org/10.1007/978-4-431-55522-3_6
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55521-6
Online ISBN: 978-4-431-55522-3
eBook Packages: MedicineMedicine (R0)